In Denmark, Weight Loss Drugs Are Reshaping the Economy

Drugs (Pharmaceuticals), Economic Conditions and Trends, Diabetes, Semaglutide (Drug), Gross Domestic Product, Ozempic (Drug)
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.

By Eshe Nelson from NYT Business https://ift.tt/3R5yjBf

Post a Comment

0 Comments